Generics - Immunologicals, Biotechnology

Filter

Popular Filters

Aduro BioTech buys all GVAX assets from BioSante; Aspen in talks to buy Merck unit

05-02-2013

Aduro BioTech, a privately-held, US venture capital backed biotechnology company, says it has acquired…

Aduro BioTechAspen PharmacareBioSante PharmaceuticalsBiotechnologyGenericsGVAXImmunologicalsMerck & CoMergers & AcquisitionsOncologyVaccines

Substitution of brand name tacrolimus with generic proves safe for transplant recipients

14-09-2011

The substitution of a brand name immunosuppressive drug with a generic (manufactured by Novartis generics…

Astellas PharmaBiotechnologyGenericsImmunologicalsPrografResearchtacrolimus

Company Spotlight

ImmunoGen

ImmunoGen

Back to top